Table of Contents:
  • Part 1: On the history of spiroergometry
  • Dynamic coupling of external to cellular respiration during exercise
  • Determination of VO₂ kinetics by means of spectral analysis: a new method for evaluation of endurance capacity
  • The importance of lactate measurement for the determination of the anaerobic threshold
  • The significance of spiroergometry from the viewpoint of sports cardiology
  • Thoracic electrical bioimpedance
  • alternative or complement in cardiopulmonary exercise testing?
  • Part 2: Role of spiroergometry in clinical [exercise] testing
  • Evaluation of the cardiopulmonary exercise tolerance inpatients with coronary artery disease (CAD) and chronic heart failure (CHF)
  • Respiratory gas analysis in patients with chronic heart failure
  • Influence of phosphodiesterase inhibitors on aerobic capacity in chronic heart failure
  • Effect of a single oral dose of the PDE inhibitor Milrinone on exercise tolerance of chronic heart failure patients
  • CPX in advanced heart failure
  • Spiroergometry in post myocardial infarction patients with compromised left ventricular function.
  • Part 3: Evaluation of algorithms for rate adaptive pacing by gas exchange measurements
  • Influence of rate responsive pacing on aerobic capacity in patients with chronotropic incompetence
  • Cardiopulmonary exercise testing in rate-modulated cardiac pacing based on minute ventilation and QT-interval
  • Evaluation of temperature- and activity-controlled rate-adaptive cardiac pacemakers by spiroergometry.
  • Part 4: Effects of inhaled Salbutamol and Oxitropium Bromide on cardiopulmonary exercise capacity in patients with chronic obstructive pulmonary disease and coronary artery disease
  • Cardiopulmonary exercise testing in the diagnosis of HIV-infected patients
  • Respiratory parameters after systemic corticotropin-releasing hormone administration.